Form 8-K - Current report:
SEC Accession No. 0001213900-20-015376
Filing Date
2020-06-19
Accepted
2020-06-19 17:20:32
Documents
3
Period of Report
2020-06-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea123229-8k_actinium.htm 8-K 15956
2 PRESS RELEASE, DATED JUNE 19, 2020 ea123229ex99-1_actinium.htm EX-99.1 12877
3 GRAPHIC ex99-1_001.jpg GRAPHIC 38325
  Complete submission text file 0001213900-20-015376.txt   82941
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 20976558
SIC: 2834 Pharmaceutical Preparations